# Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency

> **NCT07385547** · PHASE1 · RECRUITING · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 40 (estimated)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** GL0034

## Key facts

- **NCT ID:** NCT07385547
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-25
- **Primary completion:** 2026-09
- **Final completion:** 2026-09-27
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385547, "Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07385547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*